MOSCOW, 8 March – RIA Novosti. Russia, like other countries in the future, will need to help in the production of vaccines against coronavirus, said the European Commissioner for the Internal Market Thierry Breton, noting that now the priority is the production of European drugs.
“The problem with vaccines that are not … developed … neither in the US nor in Europe is that they cannot find a factory to make them … It's very difficult … A vaccine is not made like FFP2 masks,” Breton said in on the air of TV channel France2.
“The Russians … are turning to us to ensure that our factories can produce it (the vaccine). Of course, we will definitely need to help the Russians, as well as others, but at the moment, obviously, the priority is that our factories can launch European vaccines “, – he added.
The authoritative scientific journal Lancet has previously published the results of the third phase of clinical trials “Sputnik V”, confirming its high efficiency and safety. During phase III clinical trials, Sputnik V demonstrated high rates of efficacy, immunogenicity and safety – the vaccine efficacy was 91.6%. The vaccine provides complete protection against severe cases of the new coronavirus infection. The Sputnik V vaccine has already been approved in 42 countries.
RDIF previously stated that it applied for registration of the Sputnik V vaccine in the EU on January 29 through a rolling review procedure and has confirmation that the application has been accepted, the speed of its approval is determined by the European regulator.